Nichlorgin (Solution) Instructions for Use
Marketing Authorization Holder
Pharmaceutical Factory Of The State Production Association Of The Krasnoyarsk Territory (Russia)
ATC Code
D01AE (Other antifungal drugs for topical use)
Active Substance
Chlornitrophenol (Grouping Name)
Dosage Form
| Nichlorgin | Alcohol solution for external use 1%: bottle 25 ml, 50 ml, or 100 ml. |
Dosage Form, Packaging, and Composition
| Alcohol solution for external use 1% | 100 ml |
| Chlornitrophenol | 1 g |
25 ml – dark glass bottles (1) – cardboard packs.
50 ml – dark glass bottles (1) – cardboard packs.
100 ml – dark glass bottles (1) – cardboard packs.
Clinical-Pharmacological Group
External antifungal drug
Pharmacotherapeutic Group
Antifungal agent
Pharmacological Action
Antifungal agent. At a solution concentration of 0.0001%, it inhibits the growth of Microsporum canis, Trichophyton gypseum; at a concentration of 0.0007%, it inhibits the growth of Candida albicans; when the active substance content increases to 0.003%, it exhibits fungicidal action.
At a higher concentration, it exerts an antibacterial effect against gram-positive and gram-negative bacteria.
Indications
- Fungal skin lesions: rubrophytosis, tinea cruris, foot mycoses, trichophytosis, microsporia, skin candidiasis.
ICD codes
| ICD-10 code | Indication |
| B35.2 | Mycosis of hands |
| B35.3 | Tinea pedis |
| B35.4 | Tinea corporis |
| B35.6 | Tinea cruris |
| B35.8 | Other dermatophytoses |
| B37.2 | Candidiasis of skin and nails |
| ICD-11 code | Indication |
| 1F23.1Z | Candidiasis of skin or mucous membranes, unspecified |
| 1F28.2 | Dermatophytosis of foot |
| 1F28.3 | Genitofemoral dermatophytosis |
| 1F28.Y | Other specified dermatophytosis |
| 1F28.Z | Dermatophytosis, unspecified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Apply externally to the affected skin areas two to three times daily.
Continue treatment until the complete resolution of clinical manifestations.
To prevent relapse, continue application once to twice daily for an additional four to six weeks after symptoms have cleared.
Adverse Reactions
Local irritant effect at the application site is possible.
Allergic reactions, including contact dermatitis, and photodermatosis may occur.
Discontinue use if severe irritation or signs of hypersensitivity appear.
Contraindications
- Hypersensitivity to chlornitrophenol or any component of the formulation.
- Pregnancy and lactation (breastfeeding).
Use in Pregnancy and Lactation
Contraindicated during pregnancy and lactation.
Special Precautions
In case of pronounced irritant effect with daily use, a solution diluted with water 1:1 can be used.
Skin areas treated with the drug should not be exposed to sunlight.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer